LOS ANGELES, Oct 6 (Reuters) - Amgen (AMGN.O), opens new tab on Monday launched direct-to-consumer U.S. sales of its cholesterol-lowering medication Repatha at a discounted cash price, becoming the ...

Please provide your email address to receive an email when new articles are posted on . Evolocumab lowered risk for major adverse CV events in a primary prevention population. Evolocumab is the first ...

Amgen (NASDAQ:AMGN) announced on Thursday that its PCSK9 inhibitor Repatha (evolocumab) reached the primary endpoints in a Phase 3 trial designed to evaluate its effect in reducing major adverse ...

The FDA has expanded approval of Amgen’s PCSK9 inhibitor Repatha (evolocumab), permitting use in adults at increased risk of major adverse cardiovascular events due to uncontrolled LDL cholesterol, ...

The PCSK9 inhibitor evolocumab (Repatha) got the FDA's blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD). Evolocumab is now indicated for the wider pool ...

New research demonstrates how generative AI models like Google’s Gemini can be manipulated to control real-world devices. The attack, developed by Ben Nassi from Tel Aviv University, Stav Cohen from ...

Hackers are stashing malware in a place that’s largely out of the reach of most defenses—inside domain name system (DNS) records that map domain names to their corresponding numerical IP addresses.

Weight loss injections have gained popularity as a quick solution for shedding pounds, but are they safe? We’ll explore the safety, benefits and potential risks associated with weight loss injections ...

Please provide your email address to receive an email when new articles are posted on . PCSK9 inhibitors lower cholesterol and risk for heart disease, but barriers to access exist. A ...

Almost all (95%) Medicare drug plans cover Repatha. This includes standalone Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage. Repatha is a brand ...

Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday. There were no infections in the young women and girls ...